The Vanguard Group 13D and 13G filings for Emergent BioSolutions Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 6:02 pm Sale | 2026-03-13 | 13G | EMERGENT BIOSOLUTIONS INC EBS | The Vanguard Group | 0 0.000% | -3,553,999 (Position Closed) | Filing |
| 2026-01-30 1:31 pm Purchase | 2025-12-31 | 13G | EMERGENT BIOSOLUTIONS INC EBS | The Vanguard Group | 3,553,999 6.760% | 579,361 (+19.48%) | Filing |
| 2024-02-13 5:04 pm Purchase | 2023-12-29 | 13G | EMERGENT BIOSOLUTIONS INC EBS | The Vanguard Group | 2,974,638 5.730% | 328,272 (+12.40%) | Filing |
| 2023-10-10 11:07 am Sale | 2023-09-29 | 13G | EMERGENT BIOSOLUTIONS INC EBS | The Vanguard Group | 2,646,366 5.110% | -2,759,908 (-51.05%) | Filing |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | EMERGENT BIOSOLUTIONS INC EBS | The Vanguard Group | 5,406,274 10.840% | 53,322 (+1.00%) | Filing |
| 2022-03-09 08:44 am Sale | 2022-02-28 | 13G | EMERGENT BIOSOLUTIONS INC EBS | The Vanguard Group | 5,352,952 10.600% | -9,079 (-0.17%) | Filing |
| 2022-02-10 08:11 am Sale | 2021-12-31 | 13G | EMERGENT BIOSOLUTIONS INC EBS | The Vanguard Group | 5,362,031 9.970% | -54,813 (-1.01%) | Filing |
| 2021-12-09 1:54 pm Purchase | 2021-11-30 | 13G | EMERGENT BIOSOLUTIONS INC EBS | The Vanguard Group | 5,416,844 10.070% | 626,271 (+13.07%) | Filing |